Prothena Corp Public (PRTA) Long-Term Deferred Tax (2012 - 2025)
Prothena Corp Public's (PRTA) quarterly Long-Term Deferred Tax came in at $44.9 million in Q1 2025, up 22.46% year-on-year from $36.7 million in Q1 2024, and up 3.87% quarter-over-quarter from $43.2 million in Q4 2024.
Prothena Corp Public (PRTA) Long-Term Deferred Tax (2012 - 2025) Analysis & Trends
Prothena Corp Public's Long-Term Deferred Tax history runs 14 years deep, the most recent figure standing at $44.9 million for Q1 2025.
- On a quarterly basis, Long-Term Deferred Tax rose 22.46% year-over-year to $44.9 million in Q1 2025; TTM through Mar 2025 was $44.9 million, a 22.46% increase from a year earlier, with the FY2024 full-year figure at $43.2 million, up 27.58% from the prior year.
- Long-Term Deferred Tax climbed to $44.9 million in Q1 2025 per PRTA's latest filing, from $43.2 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $44.9 million in Q1 2025 and bottomed at $6.4 million in Q2 2021.
- The 5-year median for Long-Term Deferred Tax is $21.4 million (2023), against an average of $23.4 million.
- Across the five-year window, Long-Term Deferred Tax slumped 43.57% in 2021 and soared 157.45% in 2022, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $7.1 million in 2021, then surged by 157.45% to $18.2 million in 2022, then soared by 86.18% to $33.9 million in 2023, then gained by 27.58% to $43.2 million in 2024, then climbed by 3.87% to $44.9 million in 2025.
- Per Business Quant, the three latest PRTA Long-Term Deferred Tax figures stand at $44.9 million (Q1 2025), $43.2 million (Q4 2024), and $41.0 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 44.91 Mn |
| Dec 31, 2024 | 43.24 Mn |
| Sep 30, 2024 | 41.00 Mn |
| Jun 30, 2024 | 39.48 Mn |
| Mar 31, 2024 | 36.68 Mn |
| Dec 31, 2023 | 33.89 Mn |
| Sep 30, 2023 | 29.92 Mn |
| Jun 30, 2023 | 25.94 Mn |
| Mar 31, 2023 | 21.43 Mn |
| Dec 31, 2022 | 18.20 Mn |
| Sep 30, 2022 | 14.97 Mn |
| Jun 30, 2022 | 11.96 Mn |
| Mar 31, 2022 | 9.59 Mn |
| Dec 31, 2021 | 7.07 Mn |
| Sep 30, 2021 | 6.50 Mn |
| Jun 30, 2021 | 6.43 Mn |
| Mar 31, 2021 | 7.02 Mn |
| Dec 31, 2020 | 11.64 Mn |
| Sep 30, 2020 | 11.52 Mn |
| Jun 30, 2020 | 11.02 Mn |